← Open Payments lookup

RACHEL TIU: Open Payments

NPI 1780268979 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,886 in 93 payments from 12 companies in 2025. Trend: 2023 $2,553 · 2024 $2,223 · 2025 $1,886

Food & beverage: $1,886
CompanyPaymentsAmount
ABBVIE INC.23$545
Amgen Inc.25$347
UCB, Inc.9$291
PFIZER INC.10$165
GlaxoSmithKline, LLC.8$152
Genentech USA, Inc.4$97
Novartis Pharmaceuticals Corporation4$84
Boehringer Ingelheim Pharmaceuticals, Inc.3$66
E.R. Squibb & Sons, L.L.C.3$61
GENZYME CORPORATION1$33

Products named: RINVOQ, Bimzelx, BENLYSTA, XELJANZ, SKYRIZI, KRYSTEXXA, TAVNEOS, ENBREL.

Industry payments across TX — which companies pay providers there.